100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 · Chutes & Ladders—BIO lands rare disease advocate John Crowley as CEO. The redesign is tooled to give leaders more resources, Crowley said, though the restructure led to …
BIO CEO John Crowley interview: China, vaccines, and Trump - STAT
Jul 18, 2024 · W ASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial …
He Designed Drugs to Save His Children. Now He’s Working to …
Dec 5, 2023 · Nearly a quarter-century after plunging into biotech to find drugs to save Megan and her younger brother, Patrick, from a rare and deadly genetic disease, Crowley feared the …
BIO selects John Crowley as new CEO - STAT
Dec 5, 2023 · W ASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the …
John Crowley (businessman) - Wikipedia
John Francis Crowley (born April 7, 1967) is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. [1] He …
Admiral William H. McRaven speaks at BIO 2024 - Bio.News
Jun 5, 2024 · Admiral William H. McRaven sat down with BIO President & CEO John F. Crowley at the 2024 BIO Convention to discuss leadership and hope.
Meet John Crowley: Biotech Visionary, Devoted Father, and New …
Jun 17, 2024 · As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a …
John F. Crowley at GEN State of Biotechnology 2024 - Bio.News
Sep 13, 2024 · John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), gave a keynote about BIO’s work, how the current political landscape is affecting the …
Why biomanufacturing is critical for America's national security - Bio.News
Mar 20, 2024 · Bolstering America’s biomanufacturing capabilities is critical to national security and a key priority of BIO's new President & CEO, John F. Crowley.
John Crowley on biotech as a national security imperative
Apr 4, 2024 · Breaking this morning: BIO President and CEO John F. Crowley writes in STAT News why the U.S. must maintain its leadership in biotechnology (and how). Plus, dengue is …